Identification of Orally Available Synthetic Heparinoids with Potent BACE1 Inhibitory Properties
Attributed to:
Evaluation of optimised heparins as novel therapeutics for Alzheimers Disease
funded by
BBSRC
Abstract
No abstract provided
Bibliographic Information
Type: Journal Article/Review
Volume: in preparation for submission
Parent Publication: Nature Biotechnology